Home / Business and Economy / IQVIA Forecasts Profit Dip Amid Rising Costs
IQVIA Forecasts Profit Dip Amid Rising Costs
5 Feb
Summary
- IQVIA predicts 2026 profit below expectations.
- Higher interest expenses significantly impact earnings forecast.
- Despite challenges, fourth-quarter results surpassed estimates.
IQVIA Holdings anticipates its 2026 adjusted earnings per share to range between $12.55 and $12.85, falling short of the consensus estimate. This outlook is attributed to a projected increase of nearly $80 million in interest expenses stemming from financing completed in 2025 and anticipated refinancing in 2026.
Despite these headwinds, IQVIA reported strong fourth-quarter results for the period ending December 31. The company's adjusted profit per share was $3.42, surpassing the estimated $3.40, with revenue reaching $4.36 billion, also exceeding expectations of $4.24 billion. The research & development solutions unit, a key area for clinical trial services, also posted revenue of $2.33 billion, outperforming estimates.
Effective January 1, IQVIA reorganized its business segments. Contract sales operations have been combined with the technology and analytics unit to form a new "Commercial Solutions" segment. Additionally, certain real-world research offerings have been moved into the R&D segment to streamline operations.
